Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice

Yunpeng Qi1,2, Changtao Jiang1, Jie Cheng1,3, Kristopher W. Krausz1, Tiangang Li3, Jessica M. Ferrell3, Frank J. Gonzalez1, John Y.L. Chiang3
1Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
2Department of Pharmaceutical Analysis, School of Pharmacy, Second Military Medical University, Shanghai, 200433, China
3Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.

Tài liệu tham khảo

Chiang, 2009, Bile acids: regulation of synthesis, J. Lipid Res., 50, 1955, 10.1194/jlr.R900010-JLR200 Pullinger, 2002, Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype, J. Clin. Invest., 110, 109, 10.1172/JCI0215387 Hylemon, 2009, Bile acids as regulatory molecules, J. Lipid Res., 50, 1509, 10.1194/jlr.R900007-JLR200 Makishima, 1999, Identification of a nuclear receptor for bile acids, Science, 284, 1362, 10.1126/science.284.5418.1362 Parks, 1999, Bile acids: natural ligands for an orphan nuclear receptor, Science, 284, 1365, 10.1126/science.284.5418.1365 Wang, 1999, Endogenous bile acids are ligands for the nuclear receptor FXR/BAR, Mol. Cell, 3, 543, 10.1016/S1097-2765(00)80348-2 Kawamata, 2003, A G protein-coupled receptor responsive to bile acids, J. Biol. Chem., 278, 9435, 10.1074/jbc.M209706200 Maruyama, 2002, Identification of membrane-type receptor for bile acids (M-BAR), Biochem. Biophys. Res. Commun., 298, 714, 10.1016/S0006-291X(02)02550-0 Thomas, 2009, TGR5-mediated bile acid sensing controls glucose homeostasis, Cell Metab., 10, 167, 10.1016/j.cmet.2009.08.001 Alemi, 2013, The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice, Gastroenterology, 144, 145, 10.1053/j.gastro.2012.09.055 Keitel, 2009, The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders, Hepatology, 50, 861, 10.1002/hep.23032 Keitel, 2010, The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes, Biol. Chem., 391, 785, 10.1515/bc.2010.077 Studer, 2012, Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes, Hepatology, 55, 267, 10.1002/hep.24681 Inagaki, 2005, Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis, Cell Metab., 2, 217, 10.1016/j.cmet.2005.09.001 Dent, 2005, Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes, Hepatology, 42, 1291, 10.1002/hep.20942 Stravitz, 1996, Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7α-hydroxylase, Am. J. Physiol., 34, G293 Song, 2007, Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes, Hepatology, 46, 1993, 10.1002/hep.21878 Seok, 2013, Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase czeta is critical for epigenomic regulation of liver metabolic genes, J. Biol. Chem., 288, 23252, 10.1074/jbc.M113.452037 Jahan, 2005, Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene, Am. J. Physiol. Gastrointest. Liver Physiol., 288, G685, 10.1152/ajpgi.00207.2004 Li, 2006, Bile acids and cytokines inhibit the human cholesterol 7alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells, Hepatology, 43, 1202, 10.1002/hep.21183 Hait, 2009, Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate, Science, 325, 1254, 10.1126/science.1176709 Schoenfield, 1981, Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety, Ann. Intern. Med., 95, 257, 10.7326/0003-4819-95-3-257 Garg, 1994, Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial, Ann. Intern. Med., 121, 416, 10.7326/0003-4819-121-6-199409150-00004 Angelin, 1978, Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia, J. Lipid Res., 19, 1017, 10.1016/S0022-2275(20)40685-6 Zhang, 2006, Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice, Proc. Natl. Acad. Sci. U. S. A., 103, 1006, 10.1073/pnas.0506982103 Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J. Clin. Invest., 113, 1408, 10.1172/JCI21025 Ma, 2006, Farnesoid X receptor is essential for normal glucose homeostasis, J. Clin. Invest., 116, 1102, 10.1172/JCI25604 Lundasen, 2006, Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man, J. Intern. Med., 260, 530, 10.1111/j.1365-2796.2006.01731.x Tomlinson, 2002, Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity, Endocrinology, 143, 1741, 10.1210/endo.143.5.8850 Fu, 2004, Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes, Endocrinology, 145, 2594, 10.1210/en.2003-1671 Potthoff, 2011, FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway, Cell Metab., 13, 729, 10.1016/j.cmet.2011.03.019 Kir, 2011, FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis, Science, 331, 1621, 10.1126/science.1198363 Bhatnagar, 2009, Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis, J. Biol. Chem., 284, 10023, 10.1074/jbc.M808818200 Miyata, 2011, Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice, Biol. Pharm. Bull., 34, 1885, 10.1248/bpb.34.1885 Miyake, 2002, Transgenic expression of cholesterol-7α-hydroxylase prevents atherosclerosis in C57BL/6J mice, Arterioscler. Thromb. Vasc. Biol., 22, 121, 10.1161/hq0102.102588 Li, 2010, Transgenic expression of cholesterol 7α-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice, Hepatology, 52, 678, 10.1002/hep.23721 Li, 2013, Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice, Hepatology, 58, 1111, 10.1002/hep.26427 Li, 2011, Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis, Hepatology, 53, 996, 10.1002/hep.24107 Nicholson, 1999, 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data, Xenobiotica, 29, 1181, 10.1080/004982599238047 Nicholson, 2002, Metabonomics: a platform for studying drug toxicity and gene function, Nat. Rev. Drug Discov., 1, 153, 10.1038/nrd728 Oresic, 2006, Metabolomic approaches to phenotype characterization and applications to complex diseases, Expert. Rev. Mol. Diagn., 6, 575, 10.1586/14737159.6.4.575 Hartler, 2013, Bioinformatics tools and challenges in structural analysis of lipidomics MS/MS data, Brief. Bioinform., 14, 375, 10.1093/bib/bbs030 Murphy, 2013, Lipidomics applications in health, disease and nutrition research, Mol. Nutr. Food Res., 57, 1336, 10.1002/mnfr.201200863 Li, 2013, Metabolomics reveals that tumor xenografts induce liver dysfunction, Mol. Cell. Proteomics, 12, 2126, 10.1074/mcp.M113.028324 Johnson, 2012, Novel metabolites and roles for alpha-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics, Am. J. Clin. Nutr., 96, 818, 10.3945/ajcn.112.042929 Matsubara, 2012, Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis, Cell Metab., 16, 634, 10.1016/j.cmet.2012.10.006 Patterson, 2011, Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling, Cancer Res., 71, 6590, 10.1158/0008-5472.CAN-11-0885 Miyake, 2001, Increased production of Apo B100-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7α- hydroxylase, J. Biol. Chem., 276, 23304, 10.1074/jbc.M101853200 Jonsson, 2005, Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets, Analyst, 130, 701, 10.1039/B501890K Hannun, 1994, The sphingomyelin cycle and the second messenger function of ceramide, J. Biol. Chem., 269, 3125, 10.1016/S0021-9258(17)41834-5 Hammad, 2010, Blood sphingolipidomics in healthy humans: impact of sample collection methodology, J. Lipid Res., 51, 3074, 10.1194/jlr.D008532 Li, 2013, Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: method development and application in hepatocellular carcinoma, J. Chromatogr. A, 1320, 103, 10.1016/j.chroma.2013.10.064 Alewijnse, 2008, Sphingolipid signalling in the cardiovascular system: good, bad or both?, Eur. J. Pharmacol., 585, 292, 10.1016/j.ejphar.2008.02.089 Wiklund, 2008, Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models, Anal. Chem., 80, 115, 10.1021/ac0713510 Kong, 2012, Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice, Hepatology, 56, 1034, 10.1002/hep.25740 Sayin, 2013, Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist, Cell Metab., 17, 225, 10.1016/j.cmet.2013.01.003 Chanda, 2009, Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner, Hepatology, 50, 880, 10.1002/hep.23049 Garcia-Canaveras, 2011, A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations, J. Proteome Res., 10, 4825, 10.1021/pr200629p Beyoglu, 2013, The metabolomic window into hepatobiliary disease, J. Hepatol., 59, 842, 10.1016/j.jhep.2013.05.030 Chavez, 2012, A ceramide-centric view of insulin resistance, Cell Metab., 15, 585, 10.1016/j.cmet.2012.04.002 Blachnio-Zabielska, 2012, Ceramide metabolism is affected by obesity and diabetes in human adipose tissue, J. Cell. Physiol., 227, 550, 10.1002/jcp.22745 Galadari, 2013, Role of ceramide in diabetes mellitus: evidence and mechanisms, Lipids Health Dis., 12, 98, 10.1186/1476-511X-12-98 Jin, 2013, Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages, Am. J. Physiol. Endocrinol. Metab., 305, E853, 10.1152/ajpendo.00251.2013 Chocian, 2010, High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei, Mol. Cell. Biochem., 340, 125, 10.1007/s11010-010-0409-6 Gupta, 2004, Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes: role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation, J. Biol. Chem., 279, 5821, 10.1074/jbc.M310979200 Haeusler, 2013, Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids, Diabetes, 62, 4184, 10.2337/db13-0639 Aron-Wisnewsky, 2013, Gut microbiota and non-alcoholic fatty liver disease: new insights, Clin. Microbiol. Infect., 19, 338, 10.1111/1469-0691.12140 Swann, 2011, Systemic gut microbial modulation of bile acid metabolism in host tissue compartments, Proc. Natl. Acad. Sci. U. S. A., 108, 4523, 10.1073/pnas.1006734107 Miyata, 2009, Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression, J. Pharmacol. Exp.Ther., 331, 1079, 10.1124/jpet.109.160093 Hu, 2014, Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism, J. Intern. Med., 275, 27, 10.1111/joim.12140 David, 2013, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820 Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice, Nature, 487, 104, 10.1038/nature11225